Thus, the authors suggested that melatonin treatment protects AR42J cells and Sprague–Dawley rats against AP-associated injury, probably through downregulation of IRE1α-mediated JNK/NF-κB pathways [44]. The gene discussed is ERN1; the disease is alkaline phosphatase measurement.